$6.33
-0.18-2.76%
At Close: -
$7.00
0.6710.58%
After Hours: Sep 18, 8:22 AM EDT
15 minutes delayed
Comments
Loading...
Regencell Bioscience (NASDAQ:RGC) Stock, Earnings Estimates, EPS, And Revenue
Regencell Bioscience reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Jun 20
EPS
$-0.160
Quarterly Revenue
$0K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Regencell Bioscience using advanced sorting and filters.
Data brought to you by Benzinga APIs
Regencell Bioscience (RGC) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Regencell Bioscience (RGC) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Regencell Bioscience (NASDAQ:RGC) reporting earnings?
Regencell Bioscience (RGC) is scheduled to report earnings on October 25, 2024. The last reported earnings were for reported on June 20, 2024 for H1.
What were the latest earnings per share (EPS) for Regencell Bioscience (NASDAQ:RGC)?
The Actual EPS was $-0.16, which missed the estimate of $0.00.
What were Regencell Bioscience’s (NASDAQ:RGC) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.